Relationship between mast cells in the tubulointerstitium and prognosis of patients with IgA nephropathy

被引:28
作者
Kurusu, A [1 ]
Suzuki, Y [1 ]
Horikoshi, S [1 ]
Shirato, I [1 ]
Tomino, Y [1 ]
机构
[1] Juntendo Univ, Sch Med, Dept Med, Div Nephrol,Bunkyo Ku, Tokyo 1138421, Japan
来源
NEPHRON | 2001年 / 89卷 / 04期
关键词
IgA nephropathy; prognosis; mast cells; tubulointerstitial fibrosis;
D O I
10.1159/000046109
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
There have been a few reports suggesting that mast cells may play an important role in the development of fibrosis and/or the degradation of extracellular matrix. We examined the relationship between the number of distribution of mast cells in tubulointerstitium and prognosis of patients with IgA nephropathy. Renal biopsy specimens were stained with mouse monoclonal antihuman mast cell tryptase antibody and then with aniline blue. Specimens from 45 patients with IgA nephropathy and from 5 patients with minimal-change nephrotic syndrome were used. There was a significant correlation between the number of mast cells per unit area of the whole tubulointerstitium and the degree of tubulointerstitial fibrosis or renal function. Patients with IgA nephropathy were divided into two groups (group 1: 'minimal' and 'slight'; group 2: 'moderate' and 'advanced') according to the classification by a previously reported method. Mast cells were mainly observed in the fibrotic areas in group 1. In group 2, many mast cells were detected not only in the fibrotic but also in the nonfibrotic areas. It appears that the number of mast cells in the nonfibrotic areas may be one of the predictive factors for the prognosis of patients with IgA nephropathy. Copyright (C) 2001 S. Karger AG, Basel.
引用
收藏
页码:391 / 397
页数:7
相关论文
共 35 条
  • [1] Mast cells distribution in human liver disease and experimental rat liver fibrosis. Indications for mast cell participation in development of liver fibrosis
    Armbrust, T
    Batusic, D
    Ringe, B
    Ramadori, G
    [J]. JOURNAL OF HEPATOLOGY, 1997, 26 (05) : 1042 - 1054
  • [2] BERGER J, 1969, TRANSPL P, V1, P939
  • [3] MAST-CELLS CONTRIBUTION TO THE FIBROSING ALVEOLITIS OF THE SCLERODERMA LUNG
    CHANEZ, P
    LACOSTE, JY
    GUILLOT, B
    GIRON, J
    BARNEON, G
    ENANDER, I
    GODARD, P
    MICHEL, FB
    BOUSQUET, J
    [J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 147 (06): : 1497 - 1502
  • [4] TRYPTASE AND CHYMASE, MARKERS OF DISTINCT TYPES OF HUMAN MAST-CELLS
    CRAIG, SS
    SCHWARTZ, LB
    [J]. IMMUNOLOGIC RESEARCH, 1989, 8 (02) : 130 - 148
  • [5] CRAIG SS, 1986, AM J PATHOL, V124, P427
  • [6] ARTICULAR MASTOCYTOSIS IN RHEUMATOID-ARTHRITIS
    CRISP, AJ
    CHAPMAN, CM
    KIRKHAM, SE
    SCHILLER, AL
    KRANE, SM
    [J]. ARTHRITIS AND RHEUMATISM, 1984, 27 (08): : 845 - 851
  • [7] Contribution of mast cells to the tubulointerstitial lesions in IgA nephritis
    Ehara, T
    Shigematsu, H
    [J]. KIDNEY INTERNATIONAL, 1998, 54 (05) : 1675 - 1683
  • [8] Dog mastocytoma cells secrete a 92-kD gelatinase activated extracellularly by mast cell chymase
    Fang, KC
    Raymond, WW
    Lazarus, SC
    Caughey, GH
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (07) : 1589 - 1596
  • [9] GALLI SJ, 1993, NEW ENGL J MED, V328, P257
  • [10] PROMOTION OF MOUSE FIBROBLAST COLLAGEN GENE-EXPRESSION BY MAST-CELLS STIMULATED VIA THE FC(EPSILON)RI - ROLE FOR MAST CELL-DERIVED TRANSFORMING GROWTH-FACTOR-BETA AND TUMOR-NECROSIS-FACTOR-ALPHA
    GORDON, JR
    GALLI, SJ
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (06) : 2027 - 2037